Andreas Jurgeit

Director/Board Member at

Mediar Therapeutics, Inc.

Finance

Health Technology

Consumer Services

Profile

Andreas Jurgeit is currently Director at ImmunOs Therapeutics AG since 2022, Director at Mediar Therapeutics, Inc., Partner at Gimv Nederland BV since 2021, and Partner at Lundbeckfonden Emerge since 2018.
Former roles include Director at Indi Molecular, Inc., Director at Merck Ventures BV from 2016 to 2018, Investment Advisor at Redalpine Venture Partners AG in 2014, and Partner at Gimv NV.
Education includes graduate studies at the University of Innsbruck and a doctorate from the University of Zurich.

Andreas Jurgeit active positions

Companies	Position	Start
Lundbeckfonden Emerge Lundbeckfonden Emerge Investment ManagersFinance Lundbeckfonden Emerge is an active manager which provides equity funding for seed and early-stage capital requirements, and provides management support. The firm targets startups operating in health technology sector, industries such as pharmaceuticals. Lundbeckfonden Emerge invests in companies located in Denmark, and looks to take minority stake positions in its investment	Private Equity Investor	2018-12-06
ImmunOs Therapeutics AG ImmunOs Therapeutics AG BiotechnologyHealth Technology Engages in discovering and developing novel human immunomodulatory proteins	Director/Board Member	2022-06-06
Mediar Therapeutics, Inc. Mediar Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to halt and reverse fibrotic	Director/Board Member	-
Gimv Nederland BV Gimv Nederland BV Investment ManagersFinance Gimv-Nederland is a small- and medium-sized buyout specialist focused on Germany, the Netherlands and Belgium. They are an active, long-term manager which targets profitable medium-sized manufacturing, service and trading companies with good market positions. They focus on companies with positive earnings and sales of EUR 20-200 million, aiming to increase the investee company's value over the long-term. In addition to providing equity capital, the firm partners with investee management, providing advice and expertise as a majority or minority shareholder. They also provide growth capital in later rounds of financing until the portfolio company is self-financed or ready for an IPO. Gimv-Nederland's investments consist primarily of MBOs which involve expansion financing, ownership succession, business division spin-offs or other changes in shareholder structure. Gimv-NI's investment managers commit some of their personal capital to every investment.	Private Equity Investor	2021-03-31

All active positions of Andreas Jurgeit

Former positions of Andreas Jurgeit

Companies	Position	End
Indi Molecular, Inc. Indi Molecular, Inc. BiotechnologyHealth Technology Develops a synthetic class of diagnostic and therapeutic agents	Director/Board Member	2018-11-30
Merck Ventures BV Merck Ventures BV Investment ManagersFinance Merck Ventures invests in companies located in the Netherlands. The firm targets companies operating in the fields of healthcare, healthcare drug development, life science tools, electronics and frontier technology & sustainability sectors. It provides financing for early stage capital requirements.	Private Equity Investor	2018-11-30
Redalpine Venture Partners AG Redalpine Venture Partners AG Investment ManagersFinance Redalpine invests in companies located across Europe. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements.	Private Equity Analyst	2014-12-30
GIMV NV	Private Equity Investor	-

See the detail of Andreas Jurgeit's experience

Training of Andreas Jurgeit

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of Andreas Jurgeit's experience

Connections

1st degree connections

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Private companies	10
Gimv NV Gimv NV Investment ManagersFinance Acts as a private equity and venture capital firm	Finance
Gimv Nederland BV Gimv Nederland BV Investment ManagersFinance Gimv-Nederland is a small- and medium-sized buyout specialist focused on Germany, the Netherlands and Belgium. They are an active, long-term manager which targets profitable medium-sized manufacturing, service and trading companies with good market positions. They focus on companies with positive earnings and sales of EUR 20-200 million, aiming to increase the investee company's value over the long-term. In addition to providing equity capital, the firm partners with investee management, providing advice and expertise as a majority or minority shareholder. They also provide growth capital in later rounds of financing until the portfolio company is self-financed or ready for an IPO. Gimv-Nederland's investments consist primarily of MBOs which involve expansion financing, ownership succession, business division spin-offs or other changes in shareholder structure. Gimv-NI's investment managers commit some of their personal capital to every investment.	Finance
University of Innsbruck University of Innsbruck Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
University of Zurich University of Zurich Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
Redalpine Venture Partners AG Redalpine Venture Partners AG Investment ManagersFinance Redalpine invests in companies located across Europe. The firm focuses on a broad range of sectors and industries. It provides financing for early stage capital requirements.	Finance
Indi Molecular, Inc. Indi Molecular, Inc. BiotechnologyHealth Technology Develops a synthetic class of diagnostic and therapeutic agents	Health Technology
Lundbeckfonden Emerge Lundbeckfonden Emerge Investment ManagersFinance Lundbeckfonden Emerge is an active manager which provides equity funding for seed and early-stage capital requirements, and provides management support. The firm targets startups operating in health technology sector, industries such as pharmaceuticals. Lundbeckfonden Emerge invests in companies located in Denmark, and looks to take minority stake positions in its investment	Finance
Merck Ventures BV Merck Ventures BV Investment ManagersFinance Merck Ventures invests in companies located in the Netherlands. The firm targets companies operating in the fields of healthcare, healthcare drug development, life science tools, electronics and frontier technology & sustainability sectors. It provides financing for early stage capital requirements.	Finance
ImmunOs Therapeutics AG ImmunOs Therapeutics AG BiotechnologyHealth Technology Engages in discovering and developing novel human immunomodulatory proteins	Health Technology
Mediar Therapeutics, Inc. Mediar Therapeutics, Inc. BiotechnologyHealth Technology Develops therapeutics to halt and reverse fibrotic	Health Technology